Vascular Health and Risk Management

We are pleased to announce a new Article Collection in Vascular Health and Risk Management, dedicated to the game-changing role of pharmacotherapy in the management of heart failure. Since their clinical introduction, heart failure medications have revolutionized patient care, leading to improved survival, reduced hospitalization and improved quality of life in eligible patients, especially in those with reduced ejection fraction.

Given the global importance of pharmacotherapy in managing heart failure, Vascular Health and Risk Management invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies.

The collection, edited by Editor-In-Chief Professor Roland Asmar, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of pharmacotherapy in the management of heart failure, the Editors are particularly interested in papers in the following areas:

• Heart failure pathophysiology as it relates to potential therapeutic targets
• Emerging drugs for acute and chronic heart failure
• Efficacy and safety of heart failure pharmacotherapy, with special attention given to studies on patients with comorbidities
• Papers focused on the implementation of heart failure medications in clinical practice

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal scope and author submission instructions prior to submitting a manuscript. Submitting authors are eligible for a 20% discount on the Article Publishing charge. Please use the promo code VBOLK when prompted during the submission.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 April 2026.

Please contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Roland Asmar, Foundation-Medical Research Institutes (F-MRI), Switzerland

View all papers in this article collection